Randomised trial of treatment of hypertension in elderly patients in primary care
- PMID: 3094811
- PMCID: PMC1341855
- DOI: 10.1136/bmj.293.6555.1145
Randomised trial of treatment of hypertension in elderly patients in primary care
Abstract
A randomised trial of the treatment of hypertension in 884 patients aged 60 to 79 years at the onset showed a reduction of 18/11 mm Hg in blood pressure over a mean follow up period of 4.4 years. The principal antihypertensive agents were atenolol and bendrofluazide. There was a reduction in the rate of fatal stroke in the treatment group to 30% of that in the control group (95% confidence interval 11-84%, p less than 0.025). The rate of all strokes (fatal and non-fatal) in the treatment group was 58% of that in the control group (95% confidence interval 35-96%, p less than 0.03). The incidence of myocardial infarction and total mortality was unaffected by treatment. Questionnaires completed by the patients and their relatives failed to identify any differences in symptoms that were likely to be due to treatment.
Similar articles
-
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.Lancet. 2005 Sep 10-16;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1. Lancet. 2005. PMID: 16154016 Clinical Trial.
-
Atenolol versus bendroflumethiazide in middle-aged and elderly hypertensives.Acta Med Scand. 1985;218(2):165-72. doi: 10.1111/j.0954-6820.1985.tb08843.x. Acta Med Scand. 1985. PMID: 3904335 Clinical Trial.
-
Atenolol and bendrofluazide in hypertension.Br Med J. 1975 Oct 18;4(5989):133-5. doi: 10.1136/bmj.4.5989.133. Br Med J. 1975. PMID: 1104047 Free PMC article. Clinical Trial.
-
The Role of Beta-Blockers in the Treatment of Hypertension.Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36. Adv Exp Med Biol. 2017. PMID: 27957711 Review.
-
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].Drugs. 2000;59 Spec No 2:25-37. Drugs. 2000. PMID: 11002856 Review. French.
Cited by
-
Brazilian Guidelines of Hypertension - 2020.Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238. Arq Bras Cardiol. 2021. PMID: 33909761 Free PMC article. English, Portuguese. No abstract available.
-
Threshold and Target for Blood Pressure Lowering in the Elderly.Curr Atheroscler Rep. 2016 Dec;18(12):70. doi: 10.1007/s11883-016-0627-9. Curr Atheroscler Rep. 2016. PMID: 27771852 Review.
-
Management of elderly patients with sustained hypertension.BMJ. 1992 Feb 15;304(6824):412-6. doi: 10.1136/bmj.304.6824.412. BMJ. 1992. PMID: 1347711 Free PMC article.
-
Benefits of treating hypertension in the elderly: should age affect treatment decisions?Drugs Aging. 2001;18(9):631-8. doi: 10.2165/00002512-200118090-00001. Drugs Aging. 2001. PMID: 11599632 Review.
-
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses.Curr Hypertens Rep. 2013 Dec;15(6):559-74. doi: 10.1007/s11906-013-0401-0. Curr Hypertens Rep. 2013. PMID: 24158454 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical